Medicininė technika, UAB - financials and debts

Company age: 32 y. 5 mo.

Update

Medicininė technika - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 17,851 13,472 5,166 11,560 6,968 6,328 4,880 4,639
Profit before tax 906 798 621 533 726 -2,863 424 -2,011
Net profit 770 678 528 453 617 -2,863 360 -2,011
Equity 301,744 302,422 302,950 58,579 59,196 56,333 56,807 54,796
Liabilities 516 783 619 55 152 572 494 428
Non-current assets 247,131 247,131 12,109 11,767 11,675 11,585 11,639 10,656
Current assets 55,129 56,074 291,460 46,867 47,673 45,320 45,662 44,568
Total assets 302,260 303,205 303,569 58,634 59,348 56,905 57,301 55,224
Taxes paid
STI taxes - - - - - 1,362 846 1,270
Financial indicators
Revenue change y/y -32.3% -24.5% -61.7% +123.8% -39.7% -9.2% -22.9% -4.9%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 0.3% 0.2% 0.2% 0.8% 1.0% -5.0% 0.6% -3.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 0.3% 0.2% 0.2% 0.8% 1.0% -5.1% 0.6% -3.7%
Profit margin Net profit margin. Shows the overall profitability of the company. 4.3% 5.0% 10.2% 3.9% 8.9% -45.2% 7.4% -43.3%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 5.1% 5.9% 12.0% 4.6% 10.4% -45.2% 8.7% -43.3%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 7,552 5,052 2,214 5,780 3,484 3,164 2,440 2,320

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Medicininė technika - Social security debts

The amount of overdue SODRA debt for the company Medicininė technika as of the last working day is: 99 €

From To Debt, €
2026-09-14 2026-09-14 98.66
2026-09-05 2026-09-13 99.04
2026-08-26 2026-09-02 99.04
2026-08-23 2026-08-23 99.04
2026-08-19 2026-08-19 99.04
2026-08-16 2026-08-17 79.55
2026-07-27 2026-08-14 79.55
2026-07-26 2026-07-26 78.41
2026-07-23 2026-07-25 79.55
2026-07-19 2026-07-22 78.41
2026-06-16 2026-07-17 58.92
2026-06-11 2026-06-15 39.43
2026-05-18 2026-06-08 39.43
2026-05-17 2026-05-17 19.94
2026-05-06 2026-05-14 19.94
2026-05-03 2026-05-05 53.75
2026-04-27 2026-04-29 53.75
2026-04-26 2026-04-26 53.30
2026-04-24 2026-04-25 53.75
2026-04-20 2026-04-23 53.30
2026-03-29 2026-04-15 33.81
2026-03-27 2026-03-27 43.68
2026-03-26 2026-03-26 33.81
2026-03-17 2026-03-25 43.68
2026-03-15 2026-03-16 24.19
2026-02-18 2026-03-11 24.19
2026-01-21 2026-02-17 4.70
2026-01-16 2026-01-20 3.91
2025-12-17 2025-12-17 78.32
2025-11-18 2025-12-16 58.04
2025-10-27 2025-11-17 37.76
2025-10-26 2025-10-26 36.65
2025-10-23 2025-10-25 37.76
2025-10-16 2025-10-22 36.65
2025-09-16 2025-10-15 16.37
2025-08-28 2025-08-29 103.29
2025-07-28 2025-08-19 103.29
2025-07-26 2025-07-27 101.89
2025-07-24 2025-07-25 103.29
2025-07-16 2025-07-23 101.89
2025-06-17 2025-07-15 81.61
2025-06-11 2025-06-16 61.33
2025-06-08 2025-06-09 61.33
2025-05-16 2025-06-04 61.33
2025-05-04 2025-05-15 31.03
2025-05-01 2025-05-01 31.03
2025-04-30 2025-04-30 30.30
2025-04-24 2025-04-29 31.03
2025-04-16 2025-04-23 30.30
2025-03-18 2025-03-20 88.44
2025-02-18 2025-03-17 58.14
2025-01-22 2025-02-17 27.84
2025-01-16 2025-01-21 26.97
2024-12-17 2024-12-20 82.89
2024-11-18 2024-12-16 55.92
2024-10-24 2024-11-17 28.95
2024-10-18 2024-10-23 26.97
2024-09-20 2024-10-16 104.19
2024-09-17 2024-09-19 104.24
2024-08-19 2024-09-16 77.27
2024-07-24 2024-08-18 50.30
2024-07-16 2024-07-23 49.24
2024-06-19 2024-07-15 22.27
2024-05-16 2024-06-17 55.30
2024-04-23 2024-05-15 28.33
2024-04-22 2024-04-22 26.97
2024-04-16 2024-04-21 80.91
2024-03-18 2024-04-15 53.94
2024-02-19 2024-03-17 26.97
2024-01-23 2024-01-31 123.55
2024-01-16 2024-01-22 121.62
2024-01-15 2024-01-15 97.10
2023-12-18 2024-01-11 97.10
2023-11-16 2023-12-17 72.58
2023-10-30 2023-11-15 45.87
2023-10-26 2023-10-29 44.67
2023-10-25 2023-10-25 45.87
2023-10-17 2023-10-24 44.67
2023-09-18 2023-09-20 44.67
2023-08-23 2023-08-24 112.03
2023-08-17 2023-08-22 135.44
2023-07-26 2023-08-16 90.77
2023-07-24 2023-07-25 90.80
2023-07-18 2023-07-23 89.34
2023-06-16 2023-07-17 44.67
2023-05-16 2023-05-21 135.90
2023-05-02 2023-05-15 91.23
2023-04-27 2023-04-28 91.23
2023-04-26 2023-04-26 89.34
2023-04-25 2023-04-25 91.23
2023-04-18 2023-04-24 89.34
2023-03-17 2023-04-17 44.67
2023-03-01 2023-03-12 64.00
2023-02-22 2023-02-28 106.98
2023-02-17 2023-02-21 126.88
2023-02-06 2023-02-16 82.21
2023-01-23 2023-02-03 82.21
2023-01-17 2023-01-22 81.39
2022-12-16 2023-01-16 54.37
2022-11-21 2022-12-15 27.35
2022-11-17 2022-11-18 27.35
2022-10-31 2022-11-16 0.33
2022-10-18 2022-10-23 27.02
2022-09-16 2022-09-20 27.02
2022-08-23 2022-09-11 27.15
2022-07-25 2022-08-22 0.13
2022-07-18 2022-07-21 27.02
2022-06-16 2022-06-21 27.02
2022-05-17 2022-05-19 27.15
2022-04-25 2022-05-16 0.13
2022-04-19 2022-04-21 19.96
2022-03-16 2022-03-20 24.97
2022-02-17 2022-02-21 27.13
2022-01-28 2022-02-16 0.11
2022-01-18 2022-01-20 23.76
2021-12-16 2021-12-20 23.76
2021-11-16 2021-11-18 23.89
2021-11-08 2021-11-15 0.13
2021-10-18 2021-10-20 23.76
2021-09-16 2021-09-20 23.76

Medicininė technika - VMI tax arrears

From To Overdue, €
2026-01-01 2026-01-05 3.0
2025-12-30 2025-12-31 400.11
2025-12-17 2025-12-29 420.11
2025-12-01 2025-12-16 401.04
2025-11-27 2025-11-30 400.52
2025-11-24 2025-11-26 420.52
2025-11-18 2025-11-23 418.63
2025-11-02 2025-11-17 399.56
2025-10-30 2025-11-01 398.66
2025-10-22 2025-10-29 424.66
2025-10-17 2025-10-21 422.77
2025-10-02 2025-10-16 403.7
2025-09-30 2025-10-01 403.16
2025-09-26 2025-09-29 403.39
2025-09-25 2025-09-25 414.39
2025-09-17 2025-09-24 411.99
2025-09-01 2025-09-16 392.92
2025-08-28 2025-08-31 392.32
2025-08-21 2025-08-27 20.32
2025-08-09 2025-08-20 20.14
2025-08-03 2025-08-08 1.07
2025-08-02 2025-08-02 1.67
2025-07-27 2025-08-01 84.99
2025-07-25 2025-07-26 99.99
2025-07-16 2025-07-24 99.13
2025-07-02 2025-07-15 80.06
2025-07-01 2025-07-01 81.47
2025-06-30 2025-06-30 81.37
2025-06-27 2025-06-29 81.46
2025-06-26 2025-06-26 97.46
2025-06-20 2025-06-25 96.78
2025-06-18 2025-06-19 32.78
2025-06-17 2025-06-17 344.43
2025-06-02 2025-06-16 314.5
2025-05-31 2025-06-01 311.71
2025-05-28 2025-05-30 318.99
2025-05-17 2025-05-27 334.99
2025-05-01 2025-05-16 306.5
2025-04-30 2025-04-30 148.26
2025-04-28 2025-04-29 148.14
2025-03-26 2025-03-26 29.05
2025-03-20 2025-03-25 28.49
2025-03-15 2025-03-19 109.44
2025-03-02 2025-03-14 80.95
2025-02-28 2025-03-01 80.93
2025-02-27 2025-02-27 69.93
2025-02-21 2025-02-26 69.76
2025-02-20 2025-02-20 399.9
2025-02-07 2025-02-19 387.47
2025-02-02 2025-02-06 386.81
2025-01-30 2025-02-01 388.82
2025-01-22 2025-01-29 51.82
2025-01-08 2025-01-21 0.41
2025-01-01 2025-01-07 67.67
2024-12-31 2024-12-31 67.32
2024-12-30 2024-12-30 67.4
2024-12-18 2024-12-29 19.4
2024-10-01 2024-10-16 90.1

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Medicinine technika, UAB (code 134048298) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, the company generated revenue of €4.6K, compared with €4.9K in 2024 and €6.3K in 2023, showing a continued decline over the last two years. Profitability was volatile: the company posted a net profit of €360 in 2024 after a net loss of €2.9K in 2023, but returned to a net loss of €2.0K in 2025. For 2025, the profit margin was negative, indicating that operating scale remained very limited relative to costs. The balance sheet remained conservative, with total assets of €55.2K, equity of €54.8K and liabilities of only €428 at the end of 2025. The equity ratio stood at 99.2% and debt-to-equity at 0.01, reflecting very low leverage. Asset turnover was 0.08x, while ROE was -3.7% and ROA -3.6%. Revenue per employee was €2.3K and profit per employee was -€1.0K.